Download PDF
Fortschr Neurol Psychiatr 2016; 84(06): 336-343
DOI: 10.1055/s-0042-105762
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Kognitive Verhaltenstherapie von Angst und Depression bei Patienten mit Morbus Parkinson

Cognitive Behavioral Therapy for Anxiety and Depression in Patients with Parkinson’s Disease
A. Hadinia
1   Neurologie, Abt. für klinische Neurophysiologie, Universitätsspital Basel
,
A. Meyer
1   Neurologie, Abt. für klinische Neurophysiologie, Universitätsspital Basel
,
K. Nowak
1   Neurologie, Abt. für klinische Neurophysiologie, Universitätsspital Basel
,
E. Nyberg
2   Klinische Psychologie und Psychiatrie, Universität Basel, Universitäre Psychiatrische Kliniken, Basel
,
P. Fuhr
1   Neurologie, Abt. für klinische Neurophysiologie, Universitätsspital Basel
,
R-D. Stieglitz
3   Psychiatrische Universitätspoliklinik, Universitäre Psychiatrische Kliniken, Basel
,
U. Gschwandtner
1   Neurologie, Abt. für klinische Neurophysiologie, Universitätsspital Basel
› Author Affiliations
Further Information

Publication History

Publication Date:
08 July 2016 (online)

    Permissions and Reprints

Zusammenfassung

Nichtmotorische Symptome bei Patienten mit Morbus Parkinson (MP) stoßen zunehmend auf das Interesse der Forschung. Insbesondere psychische Erkrankungen wie Angst und Depression bei Patienten mit MP beziehen Fachleute oft nicht ins Diagnoseverfahren mit ein, obwohl die Prävalenzrate hoch ist. Für eine umfassende Behandlung des Gesundheitszustands dieser Patientengruppe sind eine adäquate Diagnose und eine entsprechende Therapie notwendig. Die Kognitive Verhaltenstherapie (KVT) hat sich bislang als eines der effizientesten Therapieverfahren zur Behandlung von Angst und Depression erwiesen. Sowohl im Einzel- als auch im Gruppensetting hat sich die KVT bewährt. In dieser Übersicht werden zehn Studien einander gegenübergestellt und diskutiert, die die KVT bei Parkinsonpatienten mit Angst und Depression untersucht haben. In acht Studien fand eine Einzeltherapie statt. Darin enthalten sind drei Einzelfallstudien, drei Studien ohne Kontrollgruppe und zwei kontrollierte randomisierte Studien. Zwei Interventionen fanden ausschließlich am Telefon statt. In zwei Studien wurde eine Gruppentherapie durchgeführt. Eine davon erfolgte mit einer Kontrollgruppe. Es gibt Hinweise, dass sowohl die depressiven Symptome der Patienten mit MP nach einer KVT abnahmen als auch die Angst. Kontrollierte randomisierte Designs zu dieser Frage sind selten. Die Wirksamkeit der Gruppentherapie sollte besser erforscht werden, um eine effiziente Behandlung anbieten zu können, die die speziellen Umstände von Parkinsonpatienten berücksichtigt.

Abstract

Non-motor symptoms in patients with Parkinson’s disease (PD) are gaining more and more interest. Diagnosis of mental disorders in particular, such as anxiety and depression, are often not a part of the professional’s diagnostic procedure in spite of the high prevalence rate. To provide these patients with comprehensive treatment, proper diagnosis and appropriate therapy are required. Cognitive Behavioral Therapy (CBT) has been one of the most efficient therapies for anxiety and depression, also in a group setting. This review compares studies that examined patients with PD diagnosed with anxiety disorders and/or depression. In eight studies, CBT in an individual setting was assessed. Three of these had a single case study design, three did not have a control group and two were randomized controlled trials. Two interventions were telephone-based and two were in a group therapy setting. Several results indicate that there is a decline in depressive symptoms as well as anxiety after CBT. There are very few randomized controlled studies on this issue. The efficacy of group treatment needs to be investigated better in order to offer patients effective treatment, keeping in kind their special circumstances.

Schlüsselwörter

Parkinson - Angst - Depression - Kognitive Verhaltenstherapie - Nicht motorische Symptome

Key words

Parkinson’s disease - anxiety - depression - cognitive behavioral therapy - non-motor symptoms
 

  • Literatur

  • 1 Shulman LM, Taback RL, Rabinstein AA et al. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism & Related Disorders 2002; 8: 193-197
    CrossrefPubMedGoogle Scholar
  • 2 Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. The Lancet Neurology 2006; 5: 235-245
    CrossrefPubMedGoogle Scholar
  • 3 de Lau LML, Breteler MMB. Epidemiology of Parkinson’s disease. Lancet Neurol 2006; 5: 525-535
    CrossrefPubMedGoogle Scholar
  • 4 Fernandez HH. Updates in the medical management of Parkinson’s disease. Cleve Clin J Med 2012; 79: 28-35
    CrossrefPubMedGoogle Scholar
  • 5 Ossowska K, Lorenc-Koci E. Depression in Parkinson’s disease. Pharmacological Reports 2013; 65: 1545-1557
    CrossrefPubMedGoogle Scholar
  • 6 Wolitzky-Taylor KB, Castriotta N, Lenze EJ et al. Anxiety disorders in older adults: a comprehensive review. Depress Anxiety 2010; 27: 190-211
    CrossrefPubMedGoogle Scholar
  • 7 Weintraub D, Moberg PJ, Duda JE et al. Effects of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease. J Am Geriatr Soc 2004; 52: 784-788
    CrossrefPubMedGoogle Scholar
  • 8 Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Current neurology and neuroscience reports 2005; 5: 275-283
    CrossrefPubMedGoogle Scholar
  • 9 Schrag A. Quality of life and depression in Parkinson’s disease. J Neurol Sci 2006; 248: 151-157
    CrossrefPubMedGoogle Scholar
  • 10 Martinez-Martin P. The importance of non-motor disturbances to quality of life in Parkinson’s disease. J Neurol Sci 2011; 310: 12-16
    CrossrefPubMedGoogle Scholar
  • 11 Dissanayaka NN, O’Sullivan JD, Silburn PA et al. Assessment methods and factors associated with depression in Parkinson’s disease. J Neurol Sci 2011; 310: 208-210
    CrossrefPubMedGoogle Scholar
  • 12 Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease?. Journal of Neurology, Neurosurgery and Psychiatry 2000; 69: 308-312
    CrossrefPubMedGoogle Scholar
  • 13 McDonald WM, Richard ICH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry 2003; 54: 363-375
    CrossrefPubMedGoogle Scholar
  • 14 Reijnders JS, Ehrt U, Weber WE et al. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 2008; 23: 183-189
    CrossrefPubMedGoogle Scholar
  • 15 Leentjens AF, Moonen AJ, Dujardin K et al. Depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology 2013; 81: 1036-1043
    CrossrefPubMedGoogle Scholar
  • 16 Yamanishi T, Tachibana H, Oguru M et al. Anxiety and depression in patients with Parkinson’s disease. Intern Med 2013; 52: 539-545
    CrossrefPubMedGoogle Scholar
  • 17 Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM et al. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Movement Disorders 2011; 26: 399-406
    CrossrefPubMedGoogle Scholar
  • 18 Pachana NA, Egan SJ, Laidlaw K et al. Clinical issues in the treatment of anxiety and depression in older adults with Parkinson’s disease. Mov Disord 2013; 28: 1930-1934
    CrossrefPubMedGoogle Scholar
  • 19 Rabinstein AA, Shulman LM. Management of behavioral and psychiatric problems in Parkinson’s disease. Parkinsionism and Related Disorders 2001; 7: 41-50
    PubMedGoogle Scholar
  • 20 Davies ADM, Cousins R, Turnbull CJ et al. The experience of caregiving in Parkinson’s disease. In: Purcival R, Hobson P, eds. Parkinson’s disease. Studies in psychological and social care. Leicester: PBS Books; 1999: 154-198
    Google Scholar
  • 21 Aarsland D, Larsen JP, Karlsen K et al. Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int J Geriat Psychiatry 1999; 14: 866-874
    CrossrefPubMedGoogle Scholar
  • 22 Ravenek MJ, Schneider MA. Social support for physical activity and perceptions of control in early Parkinson’s disease. Disability and Rehabilitaion 2009; 31: 1925-1936
    PubMedGoogle Scholar
  • 23 Yang S, Sajatovic M, Walter BL. Psychosocial interventions for depression and anxiety in Parkinson’s disease. Jounal of Geriatric Psychiatry and Neurology 2012; 25: 113-121
    PubMedGoogle Scholar
  • 24 Beck AT, Rush AJ, Shas BF et al. Cognitive therapy of depression. New York: Guilford Press; 1979
    Google Scholar
  • 25 Clark DA, Beck AT. Cognitive theory and therapy of anxiety and depression: Convergence with neurobiological findings. Trends in Cognitive Sciences 2010; 14: 418-424
    CrossrefPubMedGoogle Scholar
  • 26 Tolin DF. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clinical Psychology Review 2010; 30: 710-720
    CrossrefPubMedGoogle Scholar
  • 27 Borkovec TD, Rusico AM. Psychotherapy for generalized anxiety disorder. J Clin Psychiatry 2001; 62: 37-42
    PubMedGoogle Scholar
  • 28 Butler AC, Chapman JE, Forman EM et al. The empirical status of cognitive behavioral therapy: A review of meta-analyses. Clinical Psychology Review 2006; 26: 17-31
    CrossrefPubMedGoogle Scholar
  • 29 Rupke SJ, Blecke D, Renfrow M. Cognitive therapy for depression. American Family Phisician 2006; 73: 83-86
    PubMedGoogle Scholar
  • 30 Ceri E. Cognitive-behavioral therapy with older people. Advances in Psychiatric Treatment 2007; 12: 111-118
    PubMedGoogle Scholar
  • 31 Stanley MA, Wilson NL, Novy DM et al. Cognitive behavioral therapy for generalized anxiety disorder among older adults in primary care: A randomized clinical trial. JAMA 2009; 301: 1460-1467
    CrossrefPubMedGoogle Scholar
  • 32 Mohr DC, Boudewyn AC, Goodkin DE et al. Comparative outcomes for individual cognitive-behavior therapy, supportive expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 2001; 69: 942-949
    CrossrefPubMedGoogle Scholar
  • 33 Mohr DC, Classen C, Barrera M. The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychological Medicine 2004; 34: 533-541
    CrossrefPubMedGoogle Scholar
  • 34 Muslimovic D, Post B, Speelman JD et al. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-1245
    CrossrefPubMedGoogle Scholar
  • 35 Mckinlay A, Grace RC, Darlymple-Alford JC et al. Characteristics of executive function impairment in Parkinson’s disease patients without dementia. Journal oft he International Neuropsychological Society 2010; 16: 268-277
    PubMedGoogle Scholar
  • 36 Marinus J, Visser M, Verwey NA et al. Assessment of cognition in Parkinson’s disease. Neurology 2003; 61: 1222-1228
    CrossrefPubMedGoogle Scholar
  • 37 Mohlman J, Gorman JM. The role of executive functioning in CBT: A pilot study with anxious older adults. Behaviour Research and Therapy 2005; 43: 447-465
    CrossrefPubMedGoogle Scholar
  • 38 Dobkin RD, Menza M, Bienfait KL. CBT for the treatment of depression in Parkinson’s disease: A promising non-pharmacological approach. Expert Rev Neurother 2008; 8: 27-35
    CrossrefPubMedGoogle Scholar
  • 39 Hollon SD, Beck AT, Bergin AE et al. Cognitive and cognitive-behavioral therapies. In: Garfield SL, eds. Handbook of psychotherapy and behavior change. 4. Auflage. Oxford: Wiley & Sons; 1994: 428-466
    Google Scholar
  • 40 Goldapple K, Segal Z, Garson C et al. Modulation of cortical-limbic pathways in major depression: Treatment specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004; 61: 34-41
    CrossrefPubMedGoogle Scholar
  • 41 Moreno S, Margalida G, Magallon R et al. Effectiveness of group versus individual cognitive-behavioral therapy in patients with abridged somatization disorder: a randomized controlled trial. Psychosomatic Medicine 2013; 75: 600-608
    CrossrefPubMedGoogle Scholar
  • 42 Sanderson WC, Bruce TJ. Causes and management of treatment-resistant panic disorder and agoraphobia: a survey of expert therapists. Cogn Behav Pract 2007; 14: 26-35
    CrossrefPubMedGoogle Scholar
  • 43 McDermut W, Miller IW, Brown RA. The efficacy of group-psychotherapy for depression: a meta-analysis and review oft the empirical research. Clinical Psychology 2001; 8: 98-116
    PubMedGoogle Scholar
  • 44 Cole K, Vaughan FL. Brief cognitive behavioral therapy for depression associated with Parkinson’s disease: a single case series. Behavioral and Cognitive Psychotherapy 2005; 33: 89-102
    CrossrefPubMedGoogle Scholar
  • 45 Dobkin RD, Allen LA, Menza M. A cognitive behavioral treatment package for depression in Parkinson’s disease. Psychosomatics 2006; 47: 259-263
    CrossrefPubMedGoogle Scholar
  • 46 Macht M, Pasqualini MS, Taba P. Cognitive behavioral strategies for Parkinson’s disease: a report of three cases. Journal of Clinical Psychology in Medical Settings 2007; 14: 165-176
    CrossrefPubMedGoogle Scholar
  • 47 Dobkin RD, Allen LA, Menza M. Cognitive-behavioral therapy for depression in Parkinson’s disease: a pilot study. Mov Disord 2007; 22: 946-952
    CrossrefPubMedGoogle Scholar
  • 48 Farabaugh A, Locascio JJ, Yap L et al. Cognitive-behavioral therapy for patients with Parkinson’s disease and comorbid major depressive disorder. Psychosomatics 2010; 51: 124-129
    PubMedGoogle Scholar
  • 49 Dobkin RD, Menza M, Allen LA et al. Cognitive-behavioral therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiatry 2011; 168: 1066-1074
    CrossrefPubMedGoogle Scholar
  • 50 Dobkin RD, Rubino JT, Allen LA et al. Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson’s disease. J Consult Clin Psychol 2012; 80: 694-699
    CrossrefPubMedGoogle Scholar
  • 51 Veazey C, Aki SO, Cook KF et al. Prevalence and treatment of depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2005; 17: 310-323
    CrossrefPubMedGoogle Scholar
  • 52 Dobkin RD, Menza M, Allen LA et al. Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol 2011; 24: 206-214
    CrossrefPubMedGoogle Scholar
  • 53 Feeney F, Egan S, Gasson N. Treatment of depression and anxiety in Parkinson’s disease: A pilot study using group cognitive behavioral therapy. Clinical Psychologist 2005; 9: 31-38
    CrossrefPubMedGoogle Scholar
  • 54 Tiihonen S, Lankinen A, Viemerö V. An evaluation of a cognitive-behavioral patient education program for persons with Parkinson’s disease in Finland. Nordic Psychology 2008; 60: 316-331
    CrossrefPubMedGoogle Scholar
  • 55 Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Quality of Life Research 1999; 8: 447-459
    CrossrefPubMedGoogle Scholar
  • 56 Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoreical model. Social Science & Medicine 1999; 48: 1507-1515
    CrossrefPubMedGoogle Scholar